The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center Opens at Mount Sinai

 – May 14, 2015 /Press Release/  –– 

A state-of-the-art care center for patients of all ages living with inflammatory bowel disease (IBD) is now open at The Mount Sinai Hospital. The Center features personalized treatments, new strategies in disease management and the chance to participate in clinical trials of the latest treatments.   

“Our digestive disease specialists have been at the forefront of research and treatment of these chronic conditions and we are proud to have them continue their innovative work in this unique Center,” said Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “We are grateful to our donors who have made this opening possible.”

IBD, which affects around 1.4 million people in the United States alone, is caused by inflammation of the colon and small intestine and comprises two major types: Crohn’s disease and ulcerative colitis. Crohn’s disease was named for Mount Sinai physician Burrill B. Crohn, MD, after he and his colleagues first described the condition in 1932.

“Our integrated team is constantly working together to improve our understanding of these diseases,” said Bruce Sands, MD, Dr. Burrill B. Crohn Professor of Medicine and Chief of the Dr. Henry D. Janowitz Division of Gastroenterology at The Mount Sinai Hospital. “This intense collaboration, in this unique setting, will help us to identify better treatment plans for patients and further our research in this area.”

The Center is located at 17 East 102nd Street in Manhattan, where a team of gastroenterologists, along with surgeons, pathologists, nurses, social workers, researchers, nutritionists and other allied health professionals will provide children and adults with comprehensive care under one roof.

“This Center will be the heart of regional, national and international research networks dedicated to finding better therapies for IBD in the near future, and eventually, to understanding the cause of these diseases,” said Jean-Frederic Colombel, MD, Co-Director of the Center and the Director of The Leona M. and Harry B. Helmsley Charitable Trust inflammatory Bowel Disease Center at the Icahn School of Medicine at Mount Sinai.

“Our Center will provide a seamless transition from childhood to adult-based care, minimizing the challenges adolescents face as they learn to manage their own care. It will promote well-being and resiliency in children and adults with IBD throughout the lifecycle of the chronic disease,” says Marla Dubinsky, MD, Co-Director and Chief of Pediatric Gastroenterology at the Kravis Children’s Hospital at Mount Sinai.

For more information, visit www.mountsinai.org/ibd-center or call (212) 241-8100.

About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community‐based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12‐minority‐owned free‐standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.

For more information, visit http://www.mountsinai.org, or find Mount Sinai on Facebook, Twitter, YouTube and Instagram.

# # #